Subscribe

Kanamic Network Co.,LTD (3939.T)

JPY501.00 +3.00 (+0.60%)
JP JPX Healthcare Medical - Healthcare Information Services
Address Ebisu Garden Place Tower 150-6031
Tokyo, JP
CEO Keiji Yamamoto
IPO 2016-09-15
ISIN JP3215100003

Explore sections of this company profile

Description

Kanamic Network Co.,LTD, established in Tokyo, Japan, in 2000, delivers innovative digital solutions aimed at enhancing comprehensive community care across Japan. Its primary offering is a cloud-based information-sharing system that facilitates seamless collaboration among a wide range of professionals involved in in-home care, nursing, and elder care services. This platform features essential tools such as detailed care reports, service calendars, and client face sheets. Additionally, Kanamic provides specialized management software designed for various elder care operations, including residential facilities, community support centers, and in-home care assistance. The company also supports child-rearing through a dedicated system offering information distribution, consultation services, and child growth records for community-wide use. Beyond these core platforms, Kanamic Network offers a suite of complementary services, including the development of communication and application tools for medical and elderly care sectors, systems integration, website design and management, and expert consulting. The company further provides paid job placement, education, and training services. It is also active in planning, producing, and distributing web content, videos, and promotional materials, as well as organizing educational events such as lectures, seminars, and academic meetings.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
JPY501.00 +3.00 (+0.60%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
170.4K
Beta
2.78
Float Shares
22.72M
Free Float %
47.9%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-1.94% -9.34% -11.09% -7.00% -4.72% -1.37% +20.81% +9.07% -14.70% +124.72% +124.72%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
501.00
DCF (Unlevered) 448.88 -10.4%
DCF (Levered) 505.74 +0.9%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM)
Rating 2026-05 Change
Strong Buy 0 0
Buy 0 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
10.50
Safe zone
Piotroski F-Score
8 / 9
Strong
MOAT Score
9 / 10
Strong MOAT
Composite Rating
A-
Overall Score
4 / 5
High
DCF Score
4 / 5
High
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
3 / 5
Medium
P/E Score
2 / 5
Medium
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers ★ Strong MOAT
  • Revenue growth Medical - Healthcare Information Services: +14.2%
    +9.9% Q1'26: +22.5% (vs Q1'25)
  • EPS growth Medical - Healthcare Information Services: +43.1%
    +20.9% Q1'26: +28.9% (vs Q1'25)
  • FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%
    +19.9% Q1'26: +69.4% (vs Q1'25)
  • EBIT margin Medical - Healthcare Information Services: +8.8%
    +29.4% Q1'26: +32.6% (vs Q1'25)
  • ROIC Medical - Healthcare Information Services: +5.2%
    +56.4% Q1'26: +67.8% (vs Q1'25)
  • Share dilution Medical - Healthcare Information Services: -0.1%
    0.0% Q1'26: 0.0% (vs Q1'25)
  • Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×
    0.32× Q1'26: 0.20× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (2.78) × ERP
WACC = 98% × Ke + 2% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Intrinsic value (base): 448.88 Current price: 501.00
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Sep 2016
actual
Sep 2017
actual
Sep 2018
actual
Sep 2019
actual
Sep 2020
actual
Sep 2021
actual
Sep 2022
actual
Sep 2023
actual
Sep 2024
actual
Sep 2025
actual
Sep 2026
1 Rev. Ana.
1 EPS Ana.
Sep 2027
1 Rev. Ana.
1 EPS Ana.
Sep 2028
1 Rev. Ana.
1 EPS Ana.
Revenue
1.13B
est: 1.11B (+2.2%)
1.29B
est: 1.28B (+0.6%)
1.50B
est: 1.57B (-4.4%)
1.69B
est: 1.71B (-1.4%)
1.88B
est: 1.86B (+1.2%)
2.08B
est: 2.14B (-2.5%)
2.50B
est: 2.44B (+2.6%)
3.75B
est: 2.80B (+33.8%)
5.01B
est: 5.08B (-1.4%)
5.50B
est: 5.50B (+0.0%)
6.28B
6.28B – 6.28B
+14.2% YoY
7.75B
7.75B – 7.75B
+23.4% YoY
9.20B
9.20B – 9.20B
+18.7% YoY
EBITDA
337.92M
est: 446.32M (-24.3%)
418.40M
est: 518.63M (-19.3%)
487.48M
est: 635.76M (-23.3%)
675.36M
est: 690.69M (-2.2%)
789.36M
est: 751.28M (+5.1%)
977.47M
est: 862.36M (+13.3%)
1.16B
est: 985.55M (+17.9%)
1.40B
est: 1.13B (+23.6%)
1.71B
est: 2.05B (-16.4%)
2.04B
est: 2.22B (-8.3%)
2.54B
2.54B – 2.54B
+14.2% YoY
3.13B
3.13B – 3.13B
+23.4% YoY
3.72B
3.72B – 3.72B
+18.7% YoY
EBIT
252.72M
est: 366.77M (-31.1%)
333.03M
est: 426.18M (-21.9%)
380.95M
est: 522.43M (-27.1%)
545.46M
est: 567.57M (-3.9%)
654.47M
est: 617.36M (+6.0%)
841.81M
est: 708.64M (+18.8%)
984.56M
est: 809.87M (+21.6%)
1.11B
est: 929.36M (+19.3%)
1.36B
est: 1.69B (-19.4%)
1.62B
est: 1.83B (-11.3%)
2.08B
2.08B – 2.08B
+14.2% YoY
2.57B
2.57B – 2.57B
+23.4% YoY
3.05B
3.05B – 3.05B
+18.7% YoY
Net Income
165.01M
est: 209.08M (-21.1%)
223.21M
est: 183.50M (+21.6%)
256.73M
est: 245.20M (+4.7%)
357.92M
est: 333.78M (+7.2%)
472.70M
est: 427.12M (+10.7%)
579.58M
est: 503.05M (+15.2%)
685.52M
est: 560.00M (+22.4%)
763.10M
est: 688.13M (+10.9%)
919.99M
est: 1.00B (-8.1%)
1.11B
est: 1.09B (+1.8%)
1.38B
1.38B – 1.38B
+26.5% YoY
1.70B
1.70B – 1.70B
+23.0% YoY
2.15B
2.15B – 2.15B
+26.5% YoY
SGA
720.42M
est: 427.86M (+68.4%)
816.04M
est: 497.17M (+64.1%)
863.65M
est: 609.46M (+41.7%)
879.62M
est: 662.12M (+32.8%)
900.90M
est: 720.20M (+25.1%)
920.86M
est: 826.68M (+11.4%)
1.09B
est: 944.78M (+15.9%)
1.45B
est: 1.08B (+34.1%)
1.59B
est: 1.97B (-19.3%)
1.93B
est: 2.13B (-9.4%)
2.43B
2.43B – 2.43B
+14.2% YoY
3.00B
3.00B – 3.00B
+23.4% YoY
3.56B
3.56B – 3.56B
+18.7% YoY
EPS
4.16
est: 4.41 (-5.6%)
4.70
est: 3.87 (+21.6%)
5.33
est: 5.17 (+3.2%)
7.44
est: 7.03 (+5.8%)
9.82
est: 9.00 (+9.1%)
12.08
est: 10.60 (+14.0%)
14.45
est: 11.80 (+22.5%)
16.08
est: 14.50 (+10.9%)
19.38
est: 21.10 (-8.2%)
23.42
est: 23.00 (+1.8%)
29.10
29.10 – 29.10
+26.5% YoY
35.80
35.80 – 35.80
+23.0% YoY
45.30
45.30 – 45.30
+26.5% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-13 A- 4/5 4/5 5/5 5/5 3/5 2/5 2/5
2026-05-12 A- 4/5 4/5 5/5 5/5 3/5 2/5 2/5
2026-05-11 A- 4/5 4/5 5/5 5/5 3/5 2/5 2/5
2026-05-08 A 4/5 4/5 5/5 5/5 3/5 3/5 2/5
2026-05-07 A 4/5 4/5 5/5 5/5 3/5 3/5 2/5
2026-05-01 A- 4/5 4/5 5/5 5/5 2/5 3/5 1/5
2026-04-30 A- 4/5 4/5 5/5 5/5 2/5 3/5 1/5
2026-04-28 A- 4/5 4/5 5/5 5/5 2/5 3/5 2/5
2026-04-27 A- 4/5 4/5 5/5 5/5 2/5 3/5 2/5
2026-04-24 A- 4/5 4/5 5/5 5/5 2/5 3/5 2/5
2026-04-23 A- 4/5 4/5 5/5 5/5 2/5 3/5 2/5
2026-04-22 A- 4/5 4/5 5/5 5/5 2/5 3/5 2/5
2026-04-21 A- 4/5 4/5 5/5 5/5 2/5 3/5 2/5
2026-04-20 A- 4/5 4/5 5/5 5/5 2/5 3/5 2/5
2026-04-17 A- 4/5 4/5 5/5 5/5 2/5 3/5 2/5
2026-04-16 A- 4/5 4/5 5/5 5/5 2/5 3/5 2/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
1.28B
OE per share TTM
27.05
Owner's Yield
4.92%
Maintenance CapEx ratio
38.47%
Maint CapEx / Avg PPE
17.1%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
Total invested
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock Held by 25 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 Vanguard FTSE All-World ex-US Small-Cap ETF VSS 0.00% 383.5K 0.06%
2 Amundi Japan TOPIX II UCITS ETF EUR Dist JPNU.L 0.00% 19.1K 0.45%
3 Vanguard Total World Stock ETF VT 0.00% 2.38M 0.06%
4 Dimensional - International Small Cap ETF DFIS 0.00% 129.4K 0.39%
5 Vanguard ESG International Stock ETF VSGX 0.00% 92.1K 0.10%
6 Vanguard FTSE Developed All Cap ex North America Index ETF (CAD-hedged) VI.TO 0.00% 6.8K 0.22%
7 Vanguard FTSE Developed All Cap ex North America Index ETF VIU.TO 0.00% 79.1K 0.23%
8 iShares Core TOPIX ETF 1475.T 0.00% 152.8K 0.05%
9 Dimensional - International Core Equity 2 ETF DFIC 0.00% 89.3K 0.22%
10 Avantis International Small Cap Equity ETF AVDS 0.00% 1.9K 0.30%

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
5.80M
Shares Outstanding
47.46M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Keiji Yamamoto VP, CEO & Representative Director male
Takuma Yamamoto President, Chief Executive Officer & Representative Director male
Yahata Executive of IR & Public Relations
Yuji Sawa Manager of Marketing Department
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits